GE Healthcare Completes Acquisition of VersaMed Corporation

by Barbara Kram, Editor | March 26, 2008

[Note: In the United States of America, the iVent 201 is cleared by the FDA for use in the following applications: hospitals, home, patient
transport and emergency/alternate-site care venues.]

About GE Healthcare

Training and education based on your needs

Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money

GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform, treat and monitor disease, so patients can live their lives to the fullest.

GE Healthcare's broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases and other conditions earlier. Our vision for the future is to enable a new "early health" model of care focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention. Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com

About VersaMed Corporation

VersaMed, founded in 1999 and headquartered in Pearl River, New York, has approximately 100 employees worldwide. VersaMed is a leading provider of software-based, smart ventilators. VersaMed designs and manufactures the iVent line of advanced life support ventilators - ICU-grade ventilators that are compact and portable enough to go anywhere - and sells them around the world to the hospital, sub-acute, emergency transport and homecare markets. VersaMed is a private company led by an experienced team of executives, engineers, software developers and respiratory care practitioners. VersaMed's annual revenues will be in excess of $30 million and have been growing at a rate of over 30% per annum.

Back to HCB News